Vivos Inc (RDGL)

[mc73]

From their Jan 24th,2022 PR:

PROCESS/PRODUCT IMPROVEMENT

The Covid pandemic impacted our hydrogel production 2021. It removed our primary production technician and stopped the supply of one of our key production chemical components. I am pleased to report that through several months of effort involving IsoTherapeutics Group LLC, Akina Inc and Scientific Polymer Products Inc we have not only recovered from these setbacks, but have dramatically improved our polymer and hydrogel production process. We reduced the polymer production time and have increased the output by a factor of three. We have also further reduced the level of trace contaminants to be well below the FDA guidelines. The primary negative impact was to delay the initiation of the biocompatibility testing necessary for the IDE, which is now underway.

The last sentence to me tells me I'm right and you are wrong...anyone else please weigh in to let me know if I'm interpreting this incorrectly.